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ABSTRACT 
Aims: As recent conflicting reports describe genetic association between both the C- and the 
T-alleles of the dopamine D2 receptor (DRD2) C957T polymorphism (rs6277) in alcohol 
dependent subjects, our aim was to examine this polymorphism and TaqIA (rs1800497) in 
Australian alcohol dependent subjects.  Methods: The C957T polymorphism was genotyped 
in 228 patients with alcohol dependence (72 females and 156 males) and 228 healthy 
controls.  Results: The C-allele and C/C genotype of C957T was associated with alcohol 
dependence whereas the TaqIA polymorphism was not.  When analysed separately for 
C957T, males showed even stronger association with the C-allele and females showed no 
association.  C957T and TaqIA haplotyping revealed strong association with alcohol 
dependence and double genotype analysis (combining C957T and TaqIA genotypes) revealed 
the relative risk of different genotypes varied by up to 27-fold with the TT/A1A2 having an 
8.5-fold lower risk of alcohol dependence than other genotypes.  Conclusions: Decreased 
DRD2 binding associated with the C-allele of the DRD2 C957T polymorphism is likely to be 
important in the underlying pathophysiology of at least some forms of alcohol dependence 
and this effect appears to be limited to males only. 
 
  
INTRODUCTION 
Alcohol dependence is a common, chronic, disabling illness that is one of the most costly 
public health problems (Grant et al., 2004).  Twin and adoption studies indicate that heritable 
factors account for 50% to 60% of the risk for developing alcoholism and potential 
susceptibility genes have been identified by association and linkage studies (Quickfall and el-
Guebaly, 2006).  Several lines of evidence implicate the DRD2 gene as a candidate gene for 
susceptibility.  Alcohol induced drug reward is largely mediated via DRD2 (Blum et al., 
2000) and neuroimaging evidence indicates that patients with alcohol dependence have 
decreased striatal DRD2 density (Repo et al., 1999) .  Conversely, unaffected offspring of 
alcohol dependent fathers have increased striatal DRD2 density compared to those without a 
family history of this disorder, indicating that higher levels of DRD2 availability may protect 
against the development of alcohol dependence (Volkow et al., 2006).  Finally, animal data 
reveal that DRD2 over expression in the nucleus accumbens core reduces alcohol 
consumption in both alcohol preferring and non-preferring rats (Thanos et al., 2004). 
 
In vivo positron emission tomography studies have found that the C-allele of C957T 
(rs6277), a polymorphism in the DRD2 gene is associated with lower striatal DRD2 binding 
potential than the T-allele in healthy subjects (Hirvonen et al., 2004).  Contrary findings in an 
in vitro study reported an increase in DRD2 mRNA stability and protein translation 
associated with the C-allele (Duan et al., 2003).  A recent within-family association study 
reported association of the T-allele and alcohol dependence, but they could not demonstrate a 
population level association (Hill et al., 2008). 
 
Another association study of alcohol dependent patients (Berggren et al., 2006) confirmed 
earlier findings that a polymorphism in the DRD2 region, TaqIA, is associated with alcohol 
dependence (Blum et al., 1990).  This association has also been confirmed by several meta-
analyses (Young et al., 2004; Munafo et al., 2007; Smith et al., 2008; Le Foll et al., 2009) but 
it has not always been reproduced by individual studies (Anghelescu et al., 2001; Haberstick 
et al., 2007).  TaqIA is a polymorphism in the ankyrin repeat and protein kinase domain-
containing protein 1 gene (ANKK1) that is found immediately downstream from DRD2.  In a 
pharmacogenetic study, TaqIA was associated with treatment response to bromocriptine, a 
pre-synaptic DRD2 agonist (Lawford et al., 1995).  The greatest improvement in craving and 
anxiety occurred in patients receiving bromocriptine and carrying the TaqIA A1-allele.  A 
recent study found that both the C957T C-allele and the TaqIA A1-allele were associated 
with alcohol dependence, although the C957T polymorphism appeared to have a stronger 
effect (Ponce et al., 2009). 
 
As C957T and TaqIA have previously been implicated in DRD2 function, dopamine response 
and alcohol dependence, we investigated the role of these polymorphism in a case-control 
genetic association study of a treatment seeking alcohol dependent population. 
 
  
METHODS 
Subjects 
A total of 228 alcohol dependent subjects were recruited from large public hospitals in 
Brisbane, Australia.  All subjects met DSM IV (Diagnostic and Statistical Manual of Mental 
Disorders IV) criteria for Alcohol Dependence.  There were 72 females and 156 males in this 
group with a mean age of 40.7 years (s.d. 10.4 years; range 20-68 years).  All were hospital 
inpatients and represented a spectrum of disease severity.  A significant proportion (n = 65) 
of these patients were diagnosed with two or more alcohol related medical conditions such as 
pancreatitis, cirrhosis, hepatitis or peripheral neuropathy.  Alcohol dependent patients were 
excluded from the study if they had dementia, delirium, psychosis, or any other condition that 
would affect their ability to provide informed consent. 
 
The control group included 228 subjects (94 females and 134 males) with a mean age of 36.8 
years (s.d. 12.8 years; range 18-66 years).  The control group was composed of volunteers 
from the general public, hospital staff, university staff and university students.  Formal 
screening for alcohol dependence or other psychological disorders was not undertaken in the 
control population.  To minimise population stratification bias, both control and clinical 
subjects were recruited in the Brisbane region (a city of approximately 2 million inhabitants 
on the East Coast of Australia).  All subjects reported being of British or European descent. 
 
Each participant gave written informed consent.  Ethics approval was obtained from all 
institutions involved (QUT ethics number 0700000611). 
 
Genotyping 
Genotyping of the C957T polymorphism was performed by allele-specific kinetic real-time 
PCR (Lawford et al., 2005) using the Applied Biosystems 7000 sequence detection system 
(Applied Biosystems, Foster City, CA, USA).  Sequence specific primers were designed for 
the C-allele (5'-ATGGTCTCCACAGCACTCTC-3'), the T-allele (5'-
ATGGTCTCCACAGCACTCTT-3') and a common reverse primer (5'-
CATTGGGCATGGTCTGGATC-3').  A total of 5-10 ng of genomic DNA was amplified in 
1 x SYBR green PCR master mix (Applied Biosystems) containing 0.4 μM of allele specific 
forward primer and 0.4 μM of common reverse primer in a 25 μL volume.  Amplification 
conditions were: step 1, 50°C for 2 min; step 2, 95°C for 10 min; step 3, 95°C for 15 s; step 
4, 60°C for 1 min, steps 3 and 4 were repeated by 40 cycles.  A cycle time (Ct) value was 
obtained by setting the threshold during geometric phase of amplification and scored relative 
to the ΔCt generated between the matched and mismatched primer pairs.  
 
TaqI A genotyping was performed by restriction fragment length polymorphism (RFLP) 
analysis of PCR products.  A genomic sequence of 501 bp of the coding region of ANKK1 
was amplified by PCR using the forward primer 5-GCACGTGCCACCATACCC-3 and the 
reverse primer 5-TGCAGAGCAGTCAGGCTG -3.  A total of 5-10 ng of genomic DNA 
was amplified in a PCR master mix containing 0.2 M of forward primer and 0.2 M of 
reverse primer, 1x PCR buffer, 1.5 mM MgCl2, 200 M dNTPs and 1 unit of Platinum Taq 
DNA Polymerase (Invitrogen) in a 25 L volume.  Amplification conditions were: step 1: 
94°C for 4 min, step 2: 94°C for 30 s, step 3: 68°C for 30 s, step 4: 72°C for 30 s, steps 2-4 
were repeated by 40.  Amplified PCR fragments were digested with TaqI restriction enzyme 
(New England Biolabs) and digested fragments were visualized via agarose gel 
electrophoresis. 
 
Statistical analysis 
For each polymorphism, a homogeneity χ2 analysis was employed to test the hypothesis of 
homogeneity of allele frequency distributions between alcohol dependent and control 
populations.  An odds ratio with 95% confidence interval (CI) was also calculated.  Genotype 
frequencies were similarly compared between alcohol dependent and control populations.  An 
extended Mantel-Haenszel test was performed to test for a trend to alcohol dependence with 
increasing copy number (0, 1, or 2) of the allele.  Odds ratios were calculated relative to the 
homozygote for the non-associated allele and population attributable fractions calculated.  
Genotype data were entered into JLIN v1.6.0 (Carter et al., 2006) to estimate haplotype 
frequencies.  Haplotype frequencies were compared between alcohol dependent and control 
groups using a homogeneity χ2 analysis.  Each haplotype with a significant association was 
analysed in isolation by partitioning the χ2 accordingly.  Generated haplotypes were analysed 
for linkage disequilibrium (LD) measures (D' and r2) using the JLIN (Carter et al., 2006).  
The calculations for attributable risk were performed using genotypes, counting the presence 
of the C-allele as a risk factor.  Statistical tests were performed using the COMPARE2 
program from the WinPepi suite of epidemiology programs (Abramson, 2004) and SPSS 
version 16.  Hardy-Weinberg equilibrium (HWE) was computed using Utility Programs for 
Analysis of Genetic Linkage (Ott, 1988).  The analysis of genotypes under a recessive model 
involved pooling genotypes and comparing frequencies using a two-by-two contingency 
table.  For example, for the C957T polymorphism, the T/T and C/T genotypes were pooled 
for both groups and compared with the C/C genotype. 
RESULTS 
C957T genotyping 
In order to find genetic associations between alcohol dependence and polymorphisms in the 
DRD2 region, the DRD2 C957T polymorphism was genotyped in 228 unrelated alcohol 
dependent subjects and 226 unrelated Caucasian healthy control subjects.  The frequency of 
the C957T alleles in the alcohol dependent and control groups (Table 1) revealed that the C-
allele was found more frequently in the alcohol dependent group (50% of alleles) compared 
with the control group (42% of alleles) with an odds ratio (OR) of 1.37 (P = 0.019).  The 
genotype frequencies of both groups are displayed in Table 2.  The C/C genotype was over 
represented in the alcohol dependent group when compared with the control sample, with an 
OR of 1.9 (P = 0.034).  A simple comparison of the genotypes between alcohol dependent 
and control subjects just achieved significance (χ2 = 6.33, P = 0.042) but this association 
became more obvious when analysed using a Mantel-Haenszel test for trend (χ2 = 5.23, P = 
0.022).  The OR for the C/T genotype (1.27) was not significantly different from the T/T 
genotype (OR = 1) indicating that the C-allele appears to behave as a recessive allele.  When 
analysed under a C-allele recessive model, the C/C genotype is almost twice as likely to be 
found in those with alcohol dependence (OR = 1.75, 95% CI, 1.09 to 2.82; P = 0.014).  The 
attributable fraction, which is the proportion of cases in the study population that would not 
have occurred had the risk factor (risk allele) not been present, is a useful measure to quantify 
the impact of the allele on the development of alcohol dependence.  Analysis of the genotype 
data revealed that 13% (95% CI, 3.37 to 22.09%, P = 0.004) of the susceptibility to alcohol 
dependence could be attributed to having the C/C genotype of C957T polymorphism.  Both 
alcohol dependent and control groups were shown to be in Hardy-Weinberg equilibrium 
based on the respective genotype frequencies of each group (controls, χ2 = 0.077, P = 0.78; 
alcohol dependence, χ2 = 1.42, P = 0.23). 
 
Gender differences 
There has been widespread discussion of sexual dimorphism in alcohol dependence (Devaud 
and Prendergast, 2009) so we investigated association of C957T separately in male and 
female alcohol dependent subjects (Table 2).  Despite decreased power due to reduced 
numbers, the strength of association in male alcohol dependent subjects was increased 
(Mantel-Haenszel test for trend χ2 = 6.72, P = 0.009).  Indeed, male subjects with the C/C 
genotype were 2.2 times as likely to have alcohol dependence (OR = 2.17, P = 0.014).  In 
contrast, the female subjects showed no indication of association with this polymorphism 
(Mantel-Haenszel test for trend χ2 = 0.497, P = 0.481), although there were only 72 female 
subjects in the study. 
 
TaqIA genotyping 
As the TaqIA polymorphism has repeatedly been seen associated with alcohol dependence 
(Lawford et al., 1997), it was also genotyped in the same samples (one control and two 
alcohol dependent samples failed to genotype).  No association was found at the allele (2 = 
1.94, P = 0.163; Table 1) or genotype level (2 = 1.88, P = 0.39; Table 2).  The A1-allele of 
TaqIA is reported to be inherited dominantly (Lawford et al., 1997) so the genotypes were 
examined under a partial and complete dominance model.   No trend in susceptibility to 
alcohol dependence was found when analysed under a partially dominant model (Mantel-
Haenszel 2 = 1.86, P = 0.173; Table 2).  When analysed under an A1-dominant model, the 
A1-containing genotypes (A1/A1 and A1/A2) also showed no association with alcohol 
dependence (2 = 1.768, P = 0.184). 
 
Haplotype analysis 
The C957T polymorphism showed association with alcohol dependence in our study and 
TaqIA has previously been associated with alcohol dependence so haplotype analysis was 
also performed for both polymorphisms.  Haplotype frequencies for the two polymorphisms 
are shown in Table 3.  Overall haplotype frequency was highly associated with alcohol 
dependence (2 = 25.11, P = 0.00001).  This association was due to the over representation of 
the 957C/TaqI A1 haplotype in alcohol dependent patients.  The 957C/TaqI A2, 957T/TaqI 
A2 and the 957T/TaqI A1 haplotypes were not significantly associated with alcohol 
dependence.  The 957C/TaqI A1 haplotype was approximately twice as likely to be 
associated with alcohol dependence compared to the 957T/TaqI A2 haplotype.  The 
957T/TaqI A1 haplotype appears to be protective as it has an OR of 0.284, i.e. this haplotype 
is about 3.5 times less likely to be found associated with alcohol dependence than the 
957T/TaqI A2 haplotype (P = 0.002) and almost seven times less likely to be found 
associated with alcohol dependence than the 957C/TaqI A1 haplotype (OR = 6.782, P = 
4.5x10-6). 
 
Linkage disequilibrium 
The TaqI A1 and the 957C alleles were in partial linkage disequilibrium (LD) in both the 
control population D´ = 0.321 and r2 = 0.029 and the alcohol dependent population D´ = 
0.824 and r2 = 0.173.  While LD exists in the control population it is significantly larger in 
the alcohol group (Goodness-of-fit χ2 = 13.35, P = 0.001) suggesting a functional relationship 
between alleles not just LD as a consequence of genetic proximity, i.e. the polymorphisms 
are inherited together more strongly in cases because both polymorphisms have a (functional) 
role in disease, not just the C957T polymorphism. 
 
Combined C957T and TaqIA genotypes 
The combined genotypes of both the C957T polymorphism and the TaqIA polymorphism 
were scored for each individual, e.g. if a person was homozygous C/C for C957T 
polymorphism and heterozygous for the TaqIA polymorphism their combined genotype was 
recorded as CC/A1A2.  Two alcohol dependent patients failed to genotype for TaqIA so 226 
combined alcohol genotypes were obtained.  One control sample failed to genotype for 
C957T and a different control sample failed to genotype for TaqIA so 226 combined control 
genotypes were obtained (Table 4).  As there are 9 possible combined genotypes, the counts 
for each genotype are quite low and only two reached significance, the CC/A1A2 genotype 
and the TT/A1A2 genotype.  Because of the very low frequency of the 957T/ TaqI A1 
haplotype (about 7% in controls and 2% in alcohol dependent samples), no controls or 
alcohol dependent samples had the TT/A1A1 combined genotype. 
 
The TT/A2A2 combined genotype was chosen as the OR = 1 low-risk or ‘normal’ genotype.  
Examination of the ORs of each genotype reveals that there are 5 genotypes with a similar 
OR to TT/A2A2, i.e. close to 1.0.  The OR of TT/A2A2, CC/A2A2, CT/A1A1, CT/A1A2 
and CT/A2A2 vary between 0.808 and 1.25.  These can be considered ‘normal’ risk 
genotypes.  The CC/A1A1 genotype has an OR of 1.75 and the CC/A1A2 genotype has an 
OR of 3.4 so these genotypes can be considered high-risk genotypes.  The TT/A1A2 
genotype has an OR of 0.125 meaning that people with this genotype are eight times less 
likely to develop alcohol dependence than people with a normal-risk genotype.  Compared to 
people with the high-risk CC/A1A2 genotype, those with the TT/A1A2 genotype are almost 
30-times less likely to develop alcohol dependence (OR = 27.2, 2 = 24.608, P = 5x10-6). 
 
When the high-risk CC/A1A1 and CC/A1A2genoypes were combined and compared with the 
remaining genotypes, people with these genotypes were more than three times as likely to 
have alcohol dependence (OR = 3.36, 95% CI = 1.72 to 6.87, χ2 = 15.68, P = 0.00008,) and 
the attributable fraction in the population was 12.7% (95% C.I. = 6.4% to 18.6%). 
 
 
DISCUSSION 
Analysis of individual polymorphisms identified modest association between the presence of 
the C-allele of the DRD2 C957T polymorphism and alcohol dependence.  The A1 allele of 
the TaqIA polymorphism has previously been associated with alcohol dependence and we 
observed that it was more abundant in alcohol dependent patients but this observation did not 
reach significance in our study.  This may be because the A1-allele has a relatively low allele 
frequency resulting in a small effect size (Berggren et al., 2006).  Consequently, the number 
of subjects in this study might have been too small to detect association.  However, when the 
data from both polymorphisms was analysed together by haplotype and combined genotype 
analysis the observed association was much stronger.  This observation lends support to the 
argument that both polymorphisms are important in alcohol dependence and confirms the 
DRD2 gene and adjacent region (ANKK1) as an alcohol dependence susceptibility gene. 
 
While the functional role of DRD2 has been well defined in addiction and other reward 
related disorders, it is less clear what role might be played by the TaqIA polymorphism in the 
ANKK1 gene.  ANKK1 is a serine/threonine kinase that is likely to be involved in signal 
transduction.  The TaqIA polymorphism causes a non-conservative (Glu to Lys) amino acid 
change in the 11th ankyrin repeat of ANKK1.  This might affect substrate binding but it is 
unlikely to affect the structural integrity of the protein (Neville et al., 2004).  While it is 
plausible that ANKK1 is involved in transduction of signals in the dopaminergic reward 
pathway, the failure to detect its expression in whole brain homogenates does not support this 
hypothesis (Neville et al., 2004).  The most plausible explanation is that the TaqIA 
polymorphism is only associated with alcohol dependence because it is in disequilibrium with 
C957T, especially since the association seen for TaqIA is not as strong as the C957T 
polymorphism.  However, the linkage disequilibrium between C957T and TaqIA seen in 
alcohol dependent cases is almost three times higher than in controls (D´ = 0.824 in cases 
compared to D´ = 0.321 in controls), suggesting that TaqIA has a role in disease independent 
of the C957T polymorphism.  An alternative explanation for previously observed association 
with TaqIA is that the ANKK1 gene has no direct role in addiction but the proximity of TaqIA 
to C957T in the DRD2 gene (they are only separated by about 12.5 kilobases) may result in a 
change in the regulation of the DRD2 gene. 
 
DRD2 is present as both presynaptic autoreceptors and postsynaptic receptors(Grigoriadis 
and Seeman, 1984).  Dopaminergic activation of presynaptic autoreceptors decreases both 
release and synthesis of dopamine and increase dopamine reuptake (Tissari et al., 1983).  It is 
known that low DRD2 binding is associated with increased drug reinforcing effects (Volkow 
et al., 1999a) and the intensity of this reinforcement is proportional to dopamine release 
(Volkow et al., 1999b).  Reduced density of presynaptic DRD2 associated with the C/C 
genotype of C957T may result in decreased autoreceptor activity, thereby resulting in 
increased dopaminergic transmission and increased drug reward. 
 
Abstinent alcohol dependent patients have decreased DRD2 availability.  Low DRD2 
availability is also associated with increased craving for alcohol and increased risk of relapse 
(Heinz et al., 2005).  Furthermore, alcohol dependent patients exhibit diminished dopamine 
release following amphetamine challenge, reflecting decreased dopaminergic 
neurotransmission (Martinez et al., 2005).  Animal studies also show lower density of DRD2 
in alcohol-preferring rodents than in non-alcohol preferring animals (Boehme and Ciaranello, 
1981; Stefanini et al., 1992; McBride et al., 1993) and that the administration of DRD2 
agonists reduces alcohol consumption in alcohol-preferring rats (Dyr et al., 1993). 
The C/C genotype of DRD2 C957T has been associated with increased cigarette smoking in 
response to negative mood, consistent with an enhanced risk for addictive behaviour, at least 
in a sub-group of smokers (Perkins et al., 2008).  We have also recently found association 
between C957T and TaqIA genotypes and haplotypes in nicotine dependent subjects (Voisey 
et al., 2012).  Conversely, homozygotes for the T-allele have shown enhanced avoidance 
learning compared with those carrying the C-allele, indicating enhanced learning from error 
in this sub-group (Frank et al., 2007).  Impaired capacity to learn from experience is 
frequently seen in those with substance misuse. 
 
Our findings are supported by a recent study that also found a strong association between the 
C957T C-allele and alcohol dependence (Ponce et al., 2008).  They also found a weaker 
association with the TaqIA A1-allele.  However, two reports conflict with our observations.  
It has been reported that the C-allele results in higher mRNA stability in vitro (Duan et al., 
2003), which could translate into higher levels of receptor.  However, it is possible that 
individual cells in the striatum may not respond to RNA instability elements in the same 
manner in vivo.  Also, while we observed an association between the C-allele of C957T and 
alcohol dependence, a recent report found association of the T-allele in a family study but 
they could not demonstrate a population level association using limited numbers of subjects 
(81 cases and 78 controls)(Hill et al., 2008). 
 
When we analysed male and female subjects separately we found an even stronger 
association between C957T and alcohol dependence in males despite decreased power due to 
reduced numbers, while the female subjects showed no sign of any association.  It is well 
recognised that incidence and risk of developing alcohol dependence varies greatly between 
men and women (Limosin et al., 2002; Lopez-Castroman et al., 2009).  This may be due to 
significant environmental differences or the impact of those environmental differences on 
different susceptibility genes.  Alternatively, a more biological difference in brain function 
between the sexes may be a more salient contributor.  In this respect, there is growing 
evidence for in vivo gender differences in D2 dopamine receptor characteristics.  In a positron 
emission tomography study, women had higher D2 dopamine binding potentials than men in 
the frontal cortex (Kaasinen et al., 2001) and lower D2 dopamine binding potentials in striatal 
regions (Pohjalainen et al., 1998).  It is suggested (Limosin et al., 2002; Lopez-Castroman et 
al., 2009) that these differences may be reflected in gender-associated differences found in 
alcohol dependence and in the present study. 
 
Our study is one of only a few to demonstrate clear gender differences for particular 
susceptibility genes.  Some studies have examined male or female risk alone but few studies 
have directly compared genetic risk for particular polymorphisms in both men and women 
with alcohol dependence.  However, in one Spanish study of alcohol dependent subjects, an 
interleukin-1 receptor polymorphism was associated in male subjects but not female subjects 
(Saiz et al., 2009). 
 
By comparing the odds ratios of the combined genotypes of the C957T and TaqIA 
polymorphisms we observed five genotypes (representing about 87% of controls and 81% of 
alcohol cases) that had a neutral risk status for alcohol dependence, i.e. an odds ratio of about 
one.  There were two high-risk genotypes (representing about 6% of controls and 18% of 
alcohol cases) that had about 3.5 times the chance of having alcohol dependence and, 
interestingly, we found one novel low-risk genotype (representing about 7% of controls and 
less than 1% of alcohol cases) that had an 8.5 times lower risk of having alcohol dependence.   
 
While our data shows strong association between DRD2 genotypes and alcohol dependence 
the number of subjects is still modest by current expectations.  In addition, the control 
population was not formally screened for alcohol dependence or other psychological 
disorders which would be expected to decrease the power to detect associations.  
 
Our results and the data of others suggest that the D2 receptor is centrally involved in the 
development of alcohol dependence and this has implications for pharmacological 
intervention strategies.  Our findings support the conclusion that the dopamine D2 receptor 
and the dopamine pathway is important in defining genetic susceptibility to alcohol 
dependence but only in males.   
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Table 1.  Allele frequencies of C957T and TaqIA polymorphisms in patients with alcohol 
dependence compared to controls 
 
* Fisher’s exact confidence interval 
** The A1 allele is T and the A2 allele is C 
  
  Allele frequency 2 P  Odds Ratio  
C957T (rs6277) N C (%) T (%)   (95% CI*) 
Control 454 193 (42.5) 261 (57.5) 
5.47 0.019 
1.37 
(1.04-1.79) Alcohol dependence 456 229 (50.2) 227 (49.8) 
TaqIA (rs1800497)  A1** (%) A2 (%)    
Control 454 77(17.0) 377 (83.0) 
1.942 0.163 
1.27 
(0.90-1.80) Alcohol dependence 452 93 (20.6) 359 (79.4) 
Table 2.  Genotype frequencies of C957T, in patients with alcohol dependence compared to 
controls 
 N Genotype frequency 2       (P) 
C957T (rs6277)  C/C (%) C/T (%) T/T (%)  
Control 227 40 (17.6) 113 (49.8) 74 (32.6) 6.33* (0.042) 
5.23** (0.022) Alcohol dependence 228 62 (27.2) 105 (46.0) 61 (26.8) 
Odds Ratio (P)  1.88 (0.034) 1.27 (1.00) 1.00  
Alcohol dependent 
Males 
156 47 (30.1) 69 (44.2) 40 (25.7) 8.37* (0.015) 6.72** (0.009) 
Odds Ratio (P)  2.17 (0.014) 1.13 (1.00) 1.00  
Alcohol dependent 
Females 
72 15 (20.8) 36 (50.0) 21 (29.2) 0.505* (0.777) 0.497** (0.481) 
Odds Ratio (P)  1.32 (0.955) 1.12 (1.00) 1.00  
TaqIA (rs1800497)  A1/A1 (%) A1/A2 (%) A2/A2 (%)  
Control 227 8 (3.5) 61 (26.9) 158 (69.6) 
1.88* (0.390) 
1.86** (0.173) 
Alcohol dependence 226 11 (4.9) 71 (31.4) 144 (63.7)  
Odds Ratio (P)  1.88 (0.034) 1.14 (1.00) 1.00  
* Likelihood-ratio 2 test 
** Mantel-Haenszel 2 test for trend 
 
   
Table 3.  Haplotype analysis of C957T and TaqI A polymorphisms in patients with alcohol 
dependence 
Haplotype* Controls Alcohol Odds Ratio** (P) χ2**** P 
957T/TaqI A2 230 216 1 0.868 0.352 
957T/TaqI A1 30 8 0.284 (0.002) 14.124 0.0002 
957C/TaqI A2 145 143 1.05 (1.000) 0.020 0.886 
957C/TaqI A1 47 85 1.926 (0.004) 12.967 0.0003 
TOTAL 452 452  25.11 0.00001 
 
* Haplotype frequencies were estimated using JLIN.  Note, haplotypes with a missing 
genotype were omitted from the analysis (2 control and 2 alcohol dependence samples) 
** Odds ratio with respect to 957T/TaqI A1 haplotype which is more commonly associated 
with a normal phenotype 
*** Likelihood ratio 2 test comparing haplotype frequency between groups when all other 
haplotypes were pooled 
 
  
Table 4.  Combined genotype frequencies of the C957T and TaqI A polymorphisms in 
patients with alcohol dependence 
Genotype Control Alcohol OR χ2* P 
CC/A1A1 4 7 1.750 0.758 1.000 
CC/A1A2 10 34 3.400 10.219 0.01 
CC/A2A2 26 21 0.808 0.380 1.000 
CT/A1A1 4 4 1.000 0.0 1.000** 
CT/A1A2 35 35 1.000 0.0 1.000 
CT/A2A2 73 65 0.890 0.212 1.000 
TT/A1A1 0 0    
TT/A1A2 16 2 0.125 10.93 0.007 
TT/A2A2 58 58 1   
Total 226 226  28.053 0.0002 
* Likelihood-ratio Chi-square 
** At least one cell has an expected frequency < 5 
 
